In HCC, CAPN2 was found to proteolyze PTP1B to promote β-catenin expression and activity via directly phosphorylating β-catenin and through an indirect PI3K/AKT-dependent manner to increase HCC progression (Ma et al., 2022). The gene discussed is CAPN2; the disease is hepatocellular carcinoma.